Literature DB >> 9671666

Growth and fate of PSA-NCAM+ precursors of the postnatal brain.

T Ben-Hur1, B Rogister, K Murray, G Rougon, M Dubois-Dalcq.   

Abstract

Oligodendrocyte-type 2 astrocyte (O-2A) lineage cells are derived from multipotential stem cells of the developing CNS. Precursors of O-2A progenitors express the polysialylated (PSA) form of the neural cell adhesion molecule (NCAM) and are detected in neonatal rat brain glial cultures. It is unclear how such PSA-NCAM+ "pre-progenitors" are related to neural stem cells and whether they still have the potential to differentiate along several neural lineages. Here we isolated PSA-NCAM+ pre-progenitor cells from glial cultures by immunopanning and found that most of these cells expressed nestin and PDGF-receptor-alpha but not O-2A antigens. PSA-NCAM+ cells synthesized transcripts for fibroblast growth factor (FGF) receptors 1, 2, and 3 and responded to FGF2 by survival and proliferation, growing into large clusters resembling neural spheres. FGF2-induced proliferation of PSA-NCAM+ pre-progenitors was significantly enhanced by thyroid hormone (T3), which on its own did not increase cell survival or mitosis. After adhesion and withdrawal of the mitogen, spheres generated mostly oligodendrocytes and astrocytes but very rarely neurons. PSA-NCAM immunopanned cells grown in epidermal growth factor (EGF) also adopted a mostly glial fate after differentiation. In contrast, PSA-NCAM-negative cells and striatal neonatal stem cells, grown in EGF or FGF2, generated the three CNS cell types. Like neural stem cells, PSA-negative cells generated more oligodendrocytes and fewer neurons when expanded in FGF2 and T3. Thus emergence of PSA-NCAM at the surface of neonatal brain precursors coincides with their restriction to a glial fate. T3 modulates these events by enhancing PSA-NCAM+ pre-progenitor growth in FGF2 and favoring an oligodendrocyte fate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671666      PMCID: PMC6793045     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules.

Authors:  R C Armstrong; L Harvath; M E Dubois-Dalcq
Journal:  J Neurosci Res       Date:  1990-11       Impact factor: 4.164

Review 2.  Is there a neural stem cell in the mammalian forebrain?

Authors:  S Weiss; B A Reynolds; A L Vescovi; C Morshead; C G Craig; D van der Kooy
Journal:  Trends Neurosci       Date:  1996-09       Impact factor: 13.837

3.  A PDGF-regulated immediate early gene response initiates neuronal differentiation in ventricular zone progenitor cells.

Authors:  B P Williams; J K Park; J A Alberta; S G Muhlebach; G Y Hwang; T M Roberts; C D Stiles
Journal:  Neuron       Date:  1997-04       Impact factor: 17.173

4.  Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.

Authors:  O Bögler; D Wren; S C Barnett; H Land; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 5.  Cell biology of polysialic acid.

Authors:  J Z Kiss; G Rougon
Journal:  Curr Opin Neurobiol       Date:  1997-10       Impact factor: 6.627

6.  Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.

Authors:  R Bansal; A E Warrington; A L Gard; B Ranscht; S E Pfeiffer
Journal:  J Neurosci Res       Date:  1989-12       Impact factor: 4.164

7.  Expression of neurotrophins and the trk family of neurotrophin receptors in normal and hypothyroid rat brain.

Authors:  M Alvarez-Dolado; T Iglesias; A Rodríguez-Peña; J Bernal; A Muñoz
Journal:  Brain Res Mol Brain Res       Date:  1994-12

8.  Identification of major cell classes in the developing mammalian nervous system.

Authors:  S Hockfield; R D McKay
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

9.  Distinct functions for thyroid hormone receptors alpha and beta in brain development indicated by differential expression of receptor genes.

Authors:  D Forrest; F Hallböök; H Persson; B Vennström
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  47 in total

1.  Characterization and distribution of a new cell surface marker of neuronal precursors.

Authors:  W Schubert; V Coskun; M Tahmina; M S Rao; M B Luskin; Z Kaprielian
Journal:  Dev Neurosci       Date:  2000       Impact factor: 2.984

2.  Neurocan is upregulated in injured brain and in cytokine-treated astrocytes.

Authors:  R A Asher; D A Morgenstern; P S Fidler; K H Adcock; A Oohira; J E Braistead; J M Levine; R U Margolis; J H Rogers; J W Fawcett
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

3.  Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

4.  Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders.

Authors:  Aixiao Liu; Christine Stadelmann; Mario Moscarello; Wolfgang Bruck; Andre' Sobel; Fabrizio G Mastronardi; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

Review 5.  Specific protein markers for stem cell cross-talk with neighboring cells in the environment.

Authors:  Kyung Soo Park; Seung Won Shin; Jeong-Woo Choi; Soong Ho Um
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

Review 6.  Prospects for neural stem cell-based therapies for neurological diseases.

Authors:  Jaime Imitola
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

Review 7.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

8.  Leukemia inhibitory factor is essential for subventricular zone neural stem cell and progenitor homeostasis as revealed by a novel flow cytometric analysis.

Authors:  Krista D Buono; Daimler Vadlamuri; Qiong Gan; Steven W Levison
Journal:  Dev Neurosci       Date:  2012-12-14       Impact factor: 2.984

9.  Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair.

Authors:  Juan Carlos Biancotti; Shalini Kumar; Jean de Vellis
Journal:  Neurochem Res       Date:  2008-07-26       Impact factor: 3.996

10.  Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation.

Authors:  Luke Y S Oh; Adam Denninger; Jennifer S Colvin; Aditee Vyas; Shubha Tole; David M Ornitz; Rashmi Bansal
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.